Adverum Biotechnologies' Series B Round

Adverum Biotechnologies raised a round of funding on April 22, 2014.

Adverum Biotechnologies, formerly Avalanche Biotechnologies, is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.…

Articles about Adverum Biotechnologies' Series B Round: